Pfizer Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Pfizer Inc.
Quantité totale PI 3 367
Quantité totale incluant filiales 5 398 (+ 2 073 pour les filiales)
Rang # Quantité totale PI 358
Note d'activité PI 4/5.0    2 070
Rang # Activité PI 330
Activité incl filiales 3,7/5.0    2 223
Symbole boursier
ISIN US7170811035
Capitalisation 145,800M  (USD)
Industrie Drug Manufacturers - Major
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

901 429
328 311
928 10
460
 
Dernier brevet 2025 - Nitrogen-linked benzisoxazole su...
Premier brevet 1903 - Substituted tetrahydrobenzazepin...
Dernière marque 2025 - DAXCERB
Première marque 1950 - TERRAMYCIN

Filiales

111 subsidiaries with IP (1290 patents, 783 trademarks)

124 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Veterinary pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central n...
P/S Antifungal pharmaceutical preparations; Antiviral pharmaceutical preparations; Anti-inflammatory ...
P/S Providing medical information in the field of heart disease; Providing information in the field o...
P/S Pharmaceutical preparations and substances; Medicinal preparations and substances; Vaccines.
P/S Pharmaceutical preparations for the treatment of neurodegenerative, nerve, neuromuscular and brai...
P/S Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous syst...
P/S Pharmaceutical preparations and substances; sanitary preparations for medical purposes.
P/S Pharmaceutical preparations for the treatment of cancer
P/S Medical information services, namely, providing medical information on the topic of cancer; Onlin...
Invention Nitrogen-linked benzisoxazole sulfonamide derivatives. The present invention relates to compound...
Invention Glp-1 receptor agonists and uses thereof. Provided herein are 6-carboxylic acids of benzimidazol...
Invention 3,4-dihydro-2,7-naphthyridine-1,6(2h,7h)-diones as mek inhibitors. The invention relates to a me...
Invention Compounds for the treatment of braf-associated diseases and disorders. Provided herein is a comp...
P/S Medical information services, namely, providing information related to vaccines for C Difficile i...
P/S Medical syringes; Medical apparatus, namely, infusion and injection devices for administering drugs
Invention Vial for containing a pharmaceutical product and filling system suitable for filling such vials i...
Invention Glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereof. Described her...
Invention Vaccines against respiratory diseases. The present disclosure relates to hMPV F protein mutants, ...
Invention Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compou...
Invention Benzodiazepine pyrazolo carboxamides as n-protein inhibitors. The invention relates to benzodiaz...
Invention Benzodiazepine pyrazolo carboxamides as n-protein inhibitors. The invention relates to benzodiaze...
Invention Health information nework wellness platform. A system and method for providing a user with inform...
Invention Digital migraine management system. Systems and methods for assisting users in managing migraines...
2024 Invention Crystalline forms of a muscarinic m4 receptor modulator and methods of treating diseases. Crystal...
Invention Novel method of preparing ervogastat. The present invention relates to a novel method of preparin...
Invention Solid forms of 6-[4-[[3-(difluoromethoxy)-2-pyridinyl]oxy]-2-methylphenyl]-1,5-dimethyl-2,4(1h, 3...
Invention Crystalline form of 2-methoxy-n-{4-methoxy-6-[(1h-pyrazol-1-yl)methyl]-1,2-benzoxazol-3-yl}benzen...
Invention Methods and vaccine compositions for lyme disease. Described are compositions and methods for pre...
Invention Solid forms of a gabaa receptor modulator and methods of its use. Solid crystalline forms of GABA...
Invention Inhibitors. Described herein are novel compounds in an isolated or crystalline form, pharmaceuti...
Invention Nitrogen-containing heteroaryl compounds for the treatment of chronic diseases. The disclosure re...
Invention Improved methods for producing bacterial capsular saccharide glycoconjugates. The disclosure prov...
Invention Acetyl coa-carboxylase (acc) inhibitors. 12344 is H or OH; and, wherein the dashed line may be pr...
Invention Lipid compounds and uses thereof. Compounds are provided having the following structure: (I) or a...
Invention Lipid compounds and uses thereof. Compounds are provided having the following structure (I) or a ...
Invention Rna molecules. The present disclosure relates to RNA molecules encoding a respiratory syncytial v...
Invention Rna molecules. The present disclosure relates to RNA molecules encoding a Neisseria meningitidis ...
Invention Biphenyl and phenylpyridine compounds as inhibitors of kat2a and/or kat2b. The invention relates ...
Invention Biphenyl and phenylpyridine compounds. The invention relates to compounds of Formula (1): The ...
Invention Therapy for the treatment of multiple myeloma. Provided herein are methods of treating and/or man...
Invention Combination therapies for treatment of breast cancer. Provided are a combination therapy comprisi...
Invention Benzodiazepine compounds as n-protein inhibitors. The present disclosure relates to benzodiazepin...
Invention Combination therapies for treatment of breast cancer. Provided are a combination therapy compris...
Invention Novel antibodies and antibody conjugates for the treatment of metabolic disorders. Disclosed her...
Invention Synthesis of 1,5-anhydro-3-({5-chloro-4-[4-fluoro-2-(2-hydroxypropan-2-yl)-1-(propan-2-yl)-1h-ben...
Invention Immunogenic compositions against influenza. The disclosure relates to compositions and methods fo...
Invention Lfa3 variants and compositions and uses thereof. The invention provides LFA3 polypeptide molecul...
Invention Sulfonyl amide derivatives for the treatment of abnormal cell growth. The present invention rela...
2023 Invention Process and intermediates useful for preparing nirmatrelvir. The present invention is directed t...
Invention Methods for producing nucleic acids. Described are methods for producing RNA molecules in an in ...
Invention Methods for producing an adjuvant. This invention provides methods for producing homogeneous and...
Invention Computerized decision support tool and medical device for respiratory condition monitoring and ca...
Invention Methods for incorporating azido groups in bacterial capsular polysaccharides. The present invent...
Invention Coronavirus antigen variants. The present disclosure provides isolated immunogenic polypeptides ...
2022 Invention Digital medicine companion for cdk inhibitor medications for cancer patients. The present disclo...
Invention Enhancement of cd47 blockade with taxanes for cd47+ cancer therapy. The invention provides combi...
Invention Immunogenic lnp compositions and methods thereof. The invention relates to compositions and meth...